BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9788767)

  • 1. Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.
    De Vry J; Jentzsch KR
    Eur J Pharmacol; 1998 Sep; 357(1):1-8. PubMed ID: 9788767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of flesinoxan: effects of enantiomers, (S)-UH301 and WAY-100635.
    Gommans J; Hijzen TH; Maes RA; Mos J; Olivier B
    Eur J Pharmacol; 1995 Sep; 284(1-2):135-40. PubMed ID: 8549617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
    Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
    Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT1A receptor agonist BAY x 3702 prevents staurosporine-induced apoptosis.
    Suchanek B; Struppeck H; Fahrig T
    Eur J Pharmacol; 1998 Aug; 355(1):95-101. PubMed ID: 9754943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
    Dekeyne A; Rivet JM; Gobert A; Millan MJ
    Neuropharmacology; 2001 Jun; 40(7):899-910. PubMed ID: 11378160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of 5-HT1A receptor ligands by drug discrimination.
    Wolff MC; Leander JD
    Eur J Pharmacol; 1997 Aug; 333(2-3):113-22. PubMed ID: 9314023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of eltoprazine in the pigeon.
    Olivier B; Herremans A; Mos J; van Drimmelen M; Tulp M; van Oorschot R; Hijzen T
    Pharmacol Biochem Behav; 1999 Oct; 64(2):421-7. PubMed ID: 10515324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of MP-3022 on the 8-OH-DPAT-induced discriminative stimulus in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1996; 48(4):397-402. PubMed ID: 9112679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effect of flesinoxan: effect of 5-HT1A antagonists and PCPA.
    Ybema CE; Slangen JL; Olivier B
    Pharmacol Biochem Behav; 1994 Apr; 47(4):957-62. PubMed ID: 8029269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-HT1A receptor agonist Bay x 3702 inhibits apoptosis induced by serum deprivation in cultured neurons.
    Ahlemeyer B; Glaser A; Schaper C; Semkova I; Krieglstein J
    Eur J Pharmacol; 1999 Apr; 370(2):211-6. PubMed ID: 10323272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-HT1A receptor ligands in a modified Geller-Seifter conflict model in the rat.
    King CM; Gommans J; Joordens RJ; Hijzen TH; Maes RA; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):121-8. PubMed ID: 9163558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release.
    Casanovas JM; Berton O; Celada P; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):248-54. PubMed ID: 10997727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H; Velázquez-Martínez DN
    J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.